Identification and clinical evaluation of diagnostic biomarkers for ischemic cardiomyopathy based on machine learning and transcriptomics
Clinical ELISA experiments provided preliminary protein-level evidence that the serum protein levels of SEPP1, CILP, and FRZB were significantly elevated in ICM patients compared to controls, which is consistent with the bioinformatic predictions.